05 sep: Lønstigninger er urealistiske
08 sep: Boligfesten er slut
07-09-2006 11:15:00

STRATEC raises sales and earnings forecast for 2008 to 2010

Birkenfeld, September 7, 2006

STRATEC Biomedical Systems AG today published an ad-hoc announcement

(statutory company announcement) with its sales and earnings forecast

for the 2006 and 2007 financial years. Pursuant to this announcement,

the company assumes that it will be possible to increase its sales

for 2006 to between Euro 65 million and Euro 68 million (sales

corridor) and for 2007 to between Euro 75 million and Euro 78 million

(sales corridor) and to increase its earnings before tax (EBT) to

between Euro 10.5 million and Euro 11 million in 2006 (earnings

corridor) and to between Euro 14 million and Euro 15 million in 2007

(earnings corridor).

In view of the considerable increase in the basis for the 2007

financial year, based on its current planning the company expects to

achieve an annual average growth rate (CAGR) of more than 11% in the

case of sales and of more than 16% for earnings before tax (EBT) from

2008 up to and including 2010.

As a result of the basis effect (higher basis in 2007) and the

shifting of the period under consideration by one year from 2008 the

average annual growth rate (CAGR) for our key sales and earnings

figures is lower in percentage terms, yet higher in absolute terms,

in the long-term forecast (for 2008 to 2010) than in the forecast

published in December 2005 (for 2007 to 2009). Assuming that the

targets stated in our long-term forecast are met, the average annual

growth rate (CAGR) reported by the STRATEC Group for the financial

years from 2000 to 2010 would amount to more than 25% in the case of

sales and to more than 34% in the case of earnings before tax (EBT).

The forecast for 2008 to 2010 takes only limited account of the

conclusion of outstanding new development and supply agreements for

new analyzer system families with existing and new customers.

The new budget figures are considerably higher than the internal

budget targets most recently forecast in December 2005. These

forecast that the sales for the 2006 financial year would increase to

Euro 55 million to Euro 59 million (sales corridor) and that earnings

before tax (EBT) would rise to Euro 8.3 million to Euro 9.2 million

(earnings corridor). An average annual growth rate (CAGR) of more

than 15% in the case of sales and of more than 22% for earnings

before tax (EBT) was forecast for the subsequent 2007 to 2009

financial years.

The annual average growth (CAGR) reported for the financial years

from 2000 up to and including 2005 amounted to more than 32% in terms

of sales and to more than 40% in the case of earnings before tax

(EBT).

About STRATEC

STRATEC Biomedical Systems AG (http://www.stratec-biomedical.de)

designs and manufactures fully automated systems for its partners in

the fields of clinical diagnostics and biotechnology. These partners

market such systems, in general together with their own reagents, to

laboratories and research institutes around the world. The company

develops its products on the basis of its own patented technologies.

Shares in the company (SIN: 728900 / ISIN: DE0007289001) are traded

in the Prime Standard segment of the Frankfurt Stock Exchange, in the

Gate-M trading segment of the Stuttgart Stock Exchange and on other

exchanges.

The STRATEC Group comprises the listed holding company "STRATEC

Biomedical Systems AG", as well as the subsidiaries "STRATEC NewGen",

"Robion" and "Sanguin".

Further information can be obtained from:

STRATEC Biomedical Systems AG

André Loy, Investor Relations

Gewerbestrasse 37, 75217 Birkenfeld

Germany

Tel: +49 7082 7916-190

Fax: +49 7082 7916-999

E-Mail: ir@stratec-biomedical.de

--- End of Message ---

WKN: 728900; ISIN: DE0007289001;

Listed: Geregelter Markt in Frankfurter Wertpapierbörse, Gate-M in

Börse Stuttgart,

Freiverkehr in Börse Berlin Bremen, Freiverkehr in Bayerische Börse

München,

Freiverkehr in Börse Düsseldorf;

Copyright © Hugin ASA . All rights reserved.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
21 sep
BAVA
Nogle gange...bare nogle gange ville jeg godt nok vaere glad og taknemmelig hvis vi ikke evig og alt..
25
19 sep
PNDORA
Her er min model ;)      
23
21 sep
I:SP500
Hej   Der er lige nu kommet nye tal fra Conference Board omkring de ledende indikatorer. Vores konju..
21
24 sep
 
De fleste danskere, svenskere og tyskere er ikke racister. Men at se sit land blive invaderet af mus..
20
20 sep
SAS-DKK
Norwegian har gjort det flot, og konkurrence kan være godt det "kan" højne kvaliteten i nogen tilfæl..
17
20 sep
PNDORA
Donlupo - Fik du skrevet fra den forkerte profil?
15
23 sep
OMXC25
Kun 3,4 på Richerskalaen. Det er nok bare Fedekim, der har vendt sig i sengen.
14
23 sep
 
Jeg har nedskrevet min strategi efter, at jeg er blevet træt af dumme indkøb med for magt EI skramme..
13
22 sep
E:QEC
https://invst.ly/583ty   Først og fremmest, er det aldeles destruktivt læsning, at skulle købe udfra..
13
22 sep
VWS
Utroligt, at du kan noget på egen hånd, uden at inddrage "Mr.Wold". Sidst du klogede dig på Vestas, ..
12

NKT/Jyske: Triton Knoll-ordre vil give god sigtbarhed i Köln i 2019

25-09-2017 14:25:53
NKT er i favoritposition til at løbe med kabelkontrakten til det britiske havvindmølleprojekt Triton Knoll, efter at udviklerne bag, et joint venture mellem Innogy og Statkraft, har valgt den danske leverandør som den foretrukne.Kommer der i løbet af 2018 som ventet en fast og ubetinget aftale ud af det, så vil det sammen med en eventuel ordre på Borssele beta sikre NKT en god kapacitetsudnyttelse..

Aktier/middag: Nets rider på købsbølgen i let positivt marked

25-09-2017 11:43:44
Nets er den store historie på ugens første dag på fondsbørsen, efter at en amerikansk kapitalfond har lanceret et købstilbud på 33 mia. kr.Et køb har været rygtet i længere tid, men mandag blev det altså officielt, at fonden Hellman and Friedman vil købe hele Nets. Det sender aktien i betalingsselskabet i vejret.Samlet set er aktiehumøret i både Danmark og Europa lunet op i dagens løb, så det tone..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Bavarian Nordic-aktien slikker sårene efter kæmpe tab - citat
2
Vestjysk Bank: Investorgruppe har allerede tjent 3 mia. kr. - citat
3
Pandora: Amerikansk investeringsselskab øger igen short-position
4
Aktier/tendens: Købsrygterne svirrer om Nets igen
5
Aktier/middag: Nets rider på købsbølgen i let positivt marked

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
26. september 2017 00:13:54
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170925.1 - EUROWEB2 - 2017-09-26 00:13:54 - 2017-09-26 00:13:54 - 1 - Website: OKAY